 |
royalty review council management: steven antebi |
|
Steven S. Antebi
Chairman
Mr. Antebi is the President and Chairman of the Board of Maple Capital Management, an equity fund focused on investments in North America. He is also President and CEO of Galileo Partners LLC and president of Blue and Gold Enterprises Inc., funds that invest in PIPE Transactions, Registered Direct Investments, Private Placements and open market equity transactions. He is also a member of the Board of Directors of Geovax, a NIH funded Company is seeking a therapeutic solution and cure for A.I.D.S. and has served as Chairman of the Board of Epinex Diagnostics since 2009. Epinex applies expert diagnostic technology in the quantitative analysis of glycated albumen, a superior marker for diabetic control.
Mr. Antebi had a long tenure at Bear Stearns & Company in senior positions including institutional sales, trading of the firm's capital, investment banking, and syndicate. He started at Bear Stearns in 1972 as a limited partner and left the firm in 1991 as a shareholder and managing director.
Mr. Antebi has been a member of the Board of Governors of Cedars Sinai Hospital in Los Angeles for over ten years. Cedars Sinai is one of the largest hospital/research centers in the world. He is also involved with Coach for Kids, the arm of Cedars Sinai that provides mobile medical units, caring for inner city children, living below the poverty line.
He has worked extensively in collaboration with different academic and governmental organizations doing extensive research on the U.S. Economy.
Mr. Antebi's academic credits include the Anderson School of Business at the University of California at Los Angeles, Loyola University School of Law, and a UCLA undergraduate degree in history.
|
 |
|
|
|
If you would like to receive periodic news from Royalty Review Council, please subscribe to our Newsletter:
|
|
|
